Related Experiment Video

Updated: Aug 1, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
08:02

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 19, 2013

Primary pulmonary hypertension in infancy: report of two autopsy cases

M Fujinami1, T Nishikawa, A Kajita

  • 1Department of Pathology, Tokyo Women's Medical College, Japan.

Acta Cardiologica
|January 1, 1989
PubMed

Insights

Unexplained plexogenic pulmonary arteriopathy in infants shows severe pulmonary hypertension. Patho-anatomical study reveals hypertensive changes, indicating prolonged elevated pulmonary arterial pressure from early infancy.

Area of Science:

  • Pediatric Pathology
  • Cardiovascular Research
  • Pulmonary Hypertension

Background:

  • Plexogenic pulmonary arteriopathy (PPA) is a rare condition characterized by severe pulmonary hypertension.
  • Understanding the early pathological changes in infantile PPA is crucial for diagnosis and management.

Observation:

  • Two infant cases (7 months and 2 years 2 months) with unexplained PPA were examined using a patho-anatomical approach.
  • Pulmonary arteries exhibited significant hypertensive changes, graded as 3 and 4 according to Heath and Edwards' criteria.

Findings:

  • The medial configuration of the pulmonary trunk suggests sustained elevated pulmonary arterial pressure.
  • These pathological changes indicate that pulmonary arterial pressure was elevated early in life, despite the young age of the patients.

Implications:

  • These findings highlight the importance of early detection and intervention for PPA in infants.
  • The study contributes to understanding the progression of pulmonary hypertension in early childhood.

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.